Global Anticoagulants Market Report 2021 - Opportunities And Strategies, Market Forecast And Trends
6 Aug, 2021
The anticoagulants market consists of sales of anticoagulants by entities (organizations, sole traders, and partnerships) that manufacture anticoagulant drugs which keep blood vessels open and prevent the formation of blood clots. Anticoagulants are referred to as blood thinners, but they do not thin the blood, instead, they avoid or minimize clots or thrombi.
Global Anticoagulants Market Size And Drivers:/b>
The global anticoagulants market is expected to grow from $32.09 billion in 2020 to $36.50 billion in 2021 at a compound annual growth rate (CAGR) of 13.7%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The anticoagulants market is expected to reach $51.32 billion in 2025 at a CAGR of 8.9%. The increasing cardiovascular diseases are a key factor driving the growth of the anticoagulants market over the coming years.
Request For A Sample For The Global Anticoagulants Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5230&type=smp
Trends In The Global Anticoagulants Market
The ongoing clinical trials of anticoagulant treatments for COVID-19 are shaping the anticoagulants market. Major companies operating in the anticoagulants sector are concentrating on establishing clinical trials of anticoagulant medications to lower the risk of COVID-19 related blood clotting in adults. For instance, in March 2021, The National Institutes of Health (NIH) in the USA has started the final of three Phase III clinical trials of blood thinners (anticoagulants) to prohibit life-threatening blood clots in elderly people with COVID-19. The ACTIV-4 trials will help to resolve concerns about the use of anticoagulants also known as antithrombotics in the treatment for COVID-19.
Global Anticoagulants Market Segments:
The global anticoagulants market is further segmented based on drug class, route of administration, distribution channel, application, end user and geography.
By Drug Class: Factor Xa Inhibitor, Heparin And LMWH, Vitamin K Antagonist, Others
By Route Of Administration: Oral Anticoagulant, Injectable Anticoagulant
By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
By Application: Venous Thromboembolism, Atrial Fibrillation Or Flutter, Coronary Artery Disease, Others
By End User: Hospitals, Homecare, Specialty Centers, Others
By Geography: The global anticoagulants market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America was the largest region in the anticoagulants market in 2020.
Read More On The Report For The Global Anticoagulants Market At:
https://www.thebusinessresearchcompany.com/report/anticoagulants-global-market-reportAnticoagulants Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides anticoagulants market overviews, analyzes and forecasts market size and growth for the global anticoagulants market, anticoagulants market share, anticoagulants market players, anticoagulants market segments and geographies, anticoagulants market’s leading competitors’ revenues, profiles and market shares. The anticoagulants market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.